Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology
BG Nordestgaard - Circulation research, 2016 - Am Heart Assoc
Scientific interest in triglyceride-rich lipoproteins has fluctuated over the past many years,
ranging from beliefs that these lipoproteins cause atherosclerotic cardiovascular disease …
ranging from beliefs that these lipoproteins cause atherosclerotic cardiovascular disease …
Bioactive Benzofuran derivatives: A review
H Khanam - European journal of medicinal chemistry, 2015 - Elsevier
In nature's collection of biologically active heterocycles, benzofuran derivatives constitute a
major group. The broad spectrum of pharmacological activity in individual benzofurans …
major group. The broad spectrum of pharmacological activity in individual benzofurans …
Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic …
A Varbo, M Benn, A Tybjærg-Hansen… - Circulation, 2013 - Am Heart Assoc
Background—Elevated nonfasting remnant cholesterol and low-density lipoprotein (LDL)
cholesterol are causally associated with ischemic heart disease (IHD), but whether elevated …
cholesterol are causally associated with ischemic heart disease (IHD), but whether elevated …
[HTML][HTML] Why patients with familial hypercholesterolemia are at high cardiovascular risk? Beyond LDL-C levels
Familial hypercholesterolemia (FH) is a common genetic cause of elevated low-density
lipoprotein cholesterol (LDL-C) due to defective clearance of circulating LDL particles. All FH …
lipoprotein cholesterol (LDL-C) due to defective clearance of circulating LDL particles. All FH …
Biological properties of metal complexes of curcumin
Curcumin, a naturally occurring phenolic compound isolated from Curcuma longa, has
different pharmacological effects, including antiinflammatory, antimicrobial, antioxidant, and …
different pharmacological effects, including antiinflammatory, antimicrobial, antioxidant, and …
[HTML][HTML] Lipid biomarkers and atherosclerosis—old and new in cardiovascular risk in childhood
M Močnik, N Marčun Varda - International Journal of Molecular Sciences, 2023 - mdpi.com
Lipids are a complex group of molecules in the body, essential as structural, functional and
metabolic components. When disbalanced, they are regarded as a cardiovascular risk …
metabolic components. When disbalanced, they are regarded as a cardiovascular risk …
[Retracted] The Effects of Statin Therapy on Oxidized LDL and Its Antibodies: A Systematic Review and Meta‐Analysis
T Jamialahmadi, F Baratzadeh, Ž Reiner… - Oxidative medicine …, 2022 - Wiley Online Library
Background. Elevated serum low‐density lipoproteins (LDL), the substrate for the formation
of atherogenic oxidized LDLs (oxLDL), are a causal factor for atherosclerotic cardiovascular …
of atherogenic oxidized LDLs (oxLDL), are a causal factor for atherosclerotic cardiovascular …
Increased intima-media thickness of the carotid artery in childhood: a systematic review of observational studies
C Lamotte, C Iliescu, C Libersa, F Gottrand - European journal of pediatrics, 2011 - Springer
Increased carotid intima-media thickness (cIMT) in adults may be caused by a childhood
exposure to cardiovascular risk factors. We systematically reviewed observational studies to …
exposure to cardiovascular risk factors. We systematically reviewed observational studies to …
Cardiovascular risk stratification in familial hypercholesterolaemia
M Sharifi, RD Rakhit, SE Humphries, D Nair - Heart, 2016 - heart.bmj.com
Familial hypercholesterolaemia (FH) is a common autosomal-dominant disorder in most
European countries. Patients with FH are characterised by a raised level of low-density …
European countries. Patients with FH are characterised by a raised level of low-density …
Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature review
I Narverud, K Retterstøl, PO Iversen, B Halvorsen… - Atherosclerosis, 2014 - Elsevier
Objective Atherosclerosis is a multi-step process, where lipids, inflammatory and hemostatic
mediators orchestrate plaque formation and progression, which subsequently may lead to …
mediators orchestrate plaque formation and progression, which subsequently may lead to …